The Reading Frame
Published in

The Reading Frame

A Silver Bullet Against COVID Variants?

A newly-discovered drug can block infections by variant threats

Image via Pexels

Canadian researchers have discovered an antiviral drug that blocks the SARS-CoV-2 virus from infecting lung cells. Promisingly, the small molecule drug known as N-0385 was shown to be highly effective against new emerging threats, the SARS-CoV-2 variants of concern.




The Reading Frame highlights breakthroughs at the leading edge of science, technology, and innovation.

Recommended from Medium

Top 10 Things We Googled in 2020

Free The Gruffalo!

Low Risk of Blood Clots and Low Platelet Count for Covid-19 Vaccination-Evidence Based

Omicron ISN’T a Bad Cold

The Great Pause Week 104: How the 2020 Pandemic will end

Fact Check: Link between COVID-19 and 5G

The Coronavirus Infects Inner Ear Cells

Oregon ECHO: Meeting Primary Care Community’s Urgent Need for COVID-19 Guidance

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
River D'Almeida, Ph.D

River D'Almeida, Ph.D

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

More from Medium

Coffee, Wine, Chocolate: Healthy or Not?

Nanoparticles Put To the Test

Why Mucus-Eating Bacteria Stimulate a Healthy Gut

How to Lower Your Risk of Alzheimer’s Disease